Strategic Global Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-25,003
| Closed | -$4.64M | – | 136 |
|
|
2025
Q2 | $4.64M | Buy |
25,003
+1,211
| +5% | +$225K | 0.76% | 45 |
|
|
2025
Q1 | $4.98M | Sell |
23,792
-580
| -2% | -$113K | 0.99% | 33 |
|
|
2024
Q4 | $4.33M | Buy |
24,372
+3,864
| +19% | +$710K | 0.79% | 40 |
|
|
2024
Q3 | $4.05M | Sell |
20,508
-221
| -1% | -$41.2K | 0.8% | 41 |
|
|
2024
Q2 | $3.56M | Buy |
20,729
+384
| +2% | +$63.6K | 0.74% | 42 |
|
|
2024
Q1 | $3.7M | Sell |
20,345
-593
| -3% | -$102K | 0.8% | 41 |
|
|
2023
Q4 | $3.24M | Sell |
20,938
-14,568
| -41% | -$2.12M | 0.74% | 46 |
|
|
2023
Q3 | $5.29M | Sell |
35,506
-1,872
| -5% | -$275K | 0.88% | 37 |
|
|
2023
Q2 | $5.04M | Sell |
37,378
-27,151
| -42% | -$3.98M | 0.77% | 48 |
|
|
2023
Q1 | $10.3M | Sell |
64,529
-5,720
| -8% | -$874K | 1.65% | 13 |
|
|
2022
Q4 | $11.4M | Sell |
70,249
-17,720
| -20% | -$2.72M | 1.82% | 11 |
|
|
2022
Q3 | $11.8M | Sell |
87,969
-3,509
| -4% | -$504K | 1.97% | 9 |
|
|
2022
Q2 | $14M | Buy |
91,478
+9,720
| +12% | +$1.49M | 2.14% | 7 |
|
|
2022
Q1 | $13.3M | Buy |
81,758
+3,971
| +5% | +$577K | 1.94% | 9 |
|
|
2021
Q4 | $10.5M | Buy |
77,787
+6,404
| +9% | +$756K | 1.36% | 18 |
|
|
2021
Q3 | $7.7M | Buy |
71,383
+16,839
| +31% | +$1.92M | 1.13% | 25 |
|
|
2021
Q2 | $6.14M | Sell |
54,544
-2,976
| -5% | -$335K | 1.12% | 22 |
|
|
2021
Q1 | $6.22M | Buy |
57,520
+17,047
| +42% | +$1.82M | 1.12% | 22 |
|
|
2020
Q4 | $4.34M | Sell |
40,473
-873
| -2% | -$83.9K | 0.77% | 43 |
|
|
2020
Q3 | $3.62M | Buy |
41,346
+3,456
| +9% | +$325K | 0.68% | 51 |
|
|
2020
Q2 | $3.72M | Buy |
37,890
+4,070
| +12% | +$358K | 0.8% | 40 |
|
|
2020
Q1 | $2.58M | Buy |
33,820
+4,981
| +17% | +$424K | 0.66% | 47 |
|
|
2019
Q4 | $2.55M | Sell |
28,839
-266
| -0.9% | -$22.1K | 0.53% | 51 |
|
|
2019
Q3 | $2.2M | Sell |
29,105
-2,454
| -8% | -$168K | 0.5% | 52 |
|
|
2019
Q2 | $2.29M | Buy |
31,559
+215
| +0.7% | +$16.9K | 0.49% | 57 |
|
|
2019
Q1 | $2.53M | Buy |
31,344
+25,037
| +397% | +$2.05M | 0.53% | 60 |
|
|
2018
Q4 | $581K | Buy |
6,307
+28
| +0.4% | +$2.46K | 0.21% | 90 |
|
|
2018
Q3 | $594K | Buy |
+6,279
| New | +$595K | 0.18% | 105 |
|
|
2016
Q2 | – | Sell |
-17,572
| Closed | -$1M | – | 145 |
|
|
2016
Q1 | $1M | Sell |
17,572
-3,735
| -18% | -$208K | 0.43% | 76 |
|
|
2015
Q4 | $1.26M | Sell |
21,307
-15,465
| -42% | -$891K | 0.54% | 68 |
|
|
2015
Q3 | $2M | Buy |
36,772
+15,993
| +77% | +$1.04M | 0.96% | 36 |
|
|
2015
Q2 | $1.4M | Buy |
20,779
+3,140
| +18% | +$205K | 0.81% | 24 |
|
|
2015
Q1 | $1.03M | Hold |
17,639
| – | – | 0.76% | 32 |
|
|
2014
Q4 | $1.15M | Buy |
+17,639
| New | +$1.11M | 1.03% | 24 |
|
Other funds holding ABBV
Strategic Global Advisors's ABBV Position: Q3 2025 in Review
Strategic Global Advisors sold out of AbbVie (ABBV) in Q3 2025, closing a stake of 25,003 shares — an estimated $4.64M sold.
Strategic Global Advisors first reported a position in ABBV in Q4 2014 and held it in 34 quarters. The position peaked at $14M in Q2 2022. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.
- Strategic Global Advisors reported no remaining AbbVie position as of Q3 2025 after selling out during the quarter.
- Strategic Global Advisors sold 25,003 AbbVie shares in Q3 2025, an estimated $4.64M.
- Strategic Global Advisors first reported a position in AbbVie in Q4 2014 and held it in 34 quarters.
- Strategic Global Advisors's AbbVie position peaked at $14M in Q2 2022.
- 3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.
Based on Strategic Global Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.